Related Experiment Video
Updated: May 31, 2026
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
CXCL5 mediates UVB irradiation-induced pain
John M Dawes1, Margarita Calvo, James R Perkins
1Wolfson Centre for Age-Related Diseases, King's College London, London SE1 1UL, UK.
Science Translational Medicine
|July 8, 2011
Summary
Researchers identified the chemokine CXCL5 as a key player in UVB-induced inflammatory pain. This discovery could lead to improved treatments for persistent pain conditions, offering hope for better pain relief and fewer side effects.
Area of Science:
- Immunology
- Neuroscience
- Dermatology
Background:
- Persistent pain states are poorly managed with current therapies like NSAIDs and opioids, which have limitations and side effects.
- Identifying novel mediators of pain is crucial for developing more effective pain treatments.
- Inflammatory pain, particularly after UVB exposure, presents a significant therapeutic challenge.
Purpose of the Study:
- To investigate the role of previously unrecognized cytokines and chemokines in mediating inflammatory pain.
- To test the hypothesis that these mediators contribute to pain hypersensitivity.
- To identify specific molecular targets for improved pain management.
Main Methods:
- UVB irradiation was used to induce persistent pain hypersensitivity in human and rat models.
- Custom polymerase chain reaction arrays measured the expression of over 90 inflammatory mediators in skin tissue.
- CXCL5 was injected into rat skin to assess its effect on pain behavior, and its role was further investigated by neutralizing its activity.
Main Results:
- UVB exposure significantly increased the expression of known pain mediators (IL-1β, IL-6, COX-2) and dysregulated several chemokines.
- CXCL5 expression was most highly induced by UVB in human skin and replicated UVB-induced pain hypersensitivity in rats.
- CXCL5-induced hypersensitivity involved neutrophil and macrophage infiltration, and blocking CXCL5 reduced pain behaviors.
Conclusions:
- The chemokine CXCL5 is a peripheral mediator of UVB-induced inflammatory pain in both humans and rats.
- CXCL5's role in pain suggests it as a potential therapeutic target for inflammatory pain conditions.
- This study highlights the importance of chemokines in pain pathways and offers a new avenue for pain treatment development.
Related Concept Videos
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
01:08Nucleotide Excision Repair
Overview
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...